Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 146

1.

A gene-based risk score for lung cancer susceptibility in smokers and ex-smokers.

Young RP, Hopkins RJ, Hay BA, Epton MJ, Mills GD, Black PN, Gardner HD, Sullivan R, Gamble GD.

Postgrad Med J. 2009 Oct;85(1008):515-24. doi: 10.1136/pgmj.2008.077107.

PMID:
19789190
2.

Lung cancer susceptibility model based on age, family history and genetic variants.

Young RP, Hopkins RJ, Hay BA, Epton MJ, Mills GD, Black PN, Gardner HD, Sullivan R, Gamble GD.

PLoS One. 2009;4(4):e5302. doi: 10.1371/journal.pone.0005302. Epub 2009 Apr 23.

3.

Single nucleotide polymorphisms of IGFBP-3 gene and lung cancer risk in a Korean population.

Han SG, Park KH, Sung JS, Whang YM, Kim YJ, Shin ES, Lee JW, Lee HJ, Ryu JS, Choi IK, Seo JH, Kim YH.

Lung Cancer. 2008 Nov;62(2):152-61. doi: 10.1016/j.lungcan.2008.03.017. Epub 2008 May 2.

PMID:
18450319
4.
5.

Association of IL-6 gene polymorphisms and COPD in a Spanish population.

Córdoba-Lanús E, de-Torres JP, López-Aguilar C, Rodríguez-Pérez MC, Maca-Meyer N, Montejo-de-Garcini A, Aguirre-Jaime A, Pérez-Méndez L, Casanova C.

Respir Med. 2008 Dec;102(12):1805-11. doi: 10.1016/j.rmed.2008.06.012. Epub 2008 Aug 9.

6.

The NAD(P)H:quinone oxidoreductase 1 gene polymorphism and lung cancer: differential susceptibility based on smoking behavior.

Xu LL, Wain JC, Miller DP, Thurston SW, Su L, Lynch TJ, Christiani DC.

Cancer Epidemiol Biomarkers Prev. 2001 Apr;10(4):303-9.

7.

[CYP2D6*10 polymorphisms and lung cancer susceptibility].

Yan Z, Wu YM, Wu YJ.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2008 Oct;30(5):564-8. Chinese.

8.

Polymorphisms in DNA damage binding protein 2 (DDB2) and susceptibility of primary lung cancer in the Chinese: a case-control study.

Hu Z, Shao M, Yuan J, Xu L, Wang F, Wang Y, Yuan W, Qian J, Ma H, Wang Y, Liu H, Chen W, Yang L, Jin G, Huo X, Chen F, Jin L, Wei Q, Huang W, Lu D, Wu T, Shen H.

Carcinogenesis. 2006 Jul;27(7):1475-80. Epub 2006 Mar 7.

PMID:
16522664
9.

GSTM1, GSTT1, and GSTP1 polymorphism and lung cancer risk in relation to tobacco smoking.

Schneider J, Bernges U, Philipp M, Woitowitz HJ.

Cancer Lett. 2004 May 10;208(1):65-74.

PMID:
15105047
10.

A myeloperoxidase polymorphism associated with reduced risk of lung cancer.

Schabath MB, Spitz MR, Hong WK, Delclos GL, Reynolds WF, Gunn GB, Whitehead LW, Wu X.

Lung Cancer. 2002 Jul;37(1):35-40.

PMID:
12057865
11.

Bronchial epithelial Ki-67 index is related to histology, smoking, and gender, but not lung cancer or chronic obstructive pulmonary disease.

Miller YE, Blatchford P, Hyun DS, Keith RL, Kennedy TC, Wolf H, Byers T, Bunn PA Jr, Lewis MT, Franklin WA, Hirsch FR, Kittelson J.

Cancer Epidemiol Biomarkers Prev. 2007 Nov;16(11):2425-31.

12.

Susceptibility to lung cancer in light smokers associated with CYP1A1 polymorphisms in Mexican- and African-Americans.

Ishibe N, Wiencke JK, Zuo ZF, McMillan A, Spitz M, Kelsey KT.

Cancer Epidemiol Biomarkers Prev. 1997 Dec;6(12):1075-80.

13.

Association of human aryl hydrocarbon receptor gene polymorphisms with risk of lung cancer among cigarette smokers in a Chinese population.

Chen D, Tian T, Wang H, Liu H, Hu Z, Wang Y, Liu Y, Ma H, Fan W, Miao R, Sun W, Wang Y, Qian J, Jin L, Wei Q, Shen H, Huang W, Lu D.

Pharmacogenet Genomics. 2009 Jan;19(1):25-34. doi: 10.1097/FPC.0b013e328316d8d8.

PMID:
18818557
14.

Association of glutathione-S-transferase omega haplotypes with susceptibility to chronic obstructive pulmonary disease.

Yanbaeva DG, Wouters EF, Dentener MA, Spruit MA, Reynaert NL.

Free Radic Res. 2009 Aug;43(8):738-43. doi: 10.1080/10715760903038440.

PMID:
19513904
15.

Genetic susceptibility and dietary patterns in lung cancer.

Tsai YY, McGlynn KA, Hu Y, Cassidy AB, Arnold J, Engstrom PF, Buetow KH.

Lung Cancer. 2003 Sep;41(3):269-81. Erratum in: Lung Cancer. 2004 May;44(2):271.

PMID:
12928118
16.
17.
18.

The transforming growth factor-beta1 (TGFB1) gene is associated with chronic obstructive pulmonary disease (COPD).

Celedón JC, Lange C, Raby BA, Litonjua AA, Palmer LJ, DeMeo DL, Reilly JJ, Kwiatkowski DJ, Chapman HA, Laird N, Sylvia JS, Hernandez M, Speizer FE, Weiss ST, Silverman EK.

Hum Mol Genet. 2004 Aug 1;13(15):1649-56. Epub 2004 Jun 2.

PMID:
15175276
19.

Tagging single nucleotide polymorphisms in MBD4 are associated with risk of lung cancer in a Chinese population.

Miao R, Gu H, Liu H, Hu Z, Jin G, Wang H, Wang Y, Sun W, Ma H, Chen D, Tian T, Jin L, Wei Q, Lu D, Huang W, Shen H.

Lung Cancer. 2008 Dec;62(3):281-6. doi: 10.1016/j.lungcan.2008.03.027. Epub 2008 May 20.

PMID:
18495292
20.

Metabolic gene polymorphisms and lung cancer risk in non-smokers. An update of the GSEC study.

Raimondi S, Boffetta P, Anttila S, Bröckmoller J, Butkiewicz D, Cascorbi I, Clapper ML, Dragani TA, Garte S, Gsur A, Haidinger G, Hirvonen A, Ingelman-Sundberg M, Kalina I, Lan Q, Leoni VP, Le Marchand L, London SJ, Neri M, Povey AC, Rannug A, Reszka E, Ryberg D, Risch A, Romkes M, Ruano-Ravina A, Schoket B, Spinola M, Sugimura H, Wu X, Taioli E.

Mutat Res. 2005 Dec 30;592(1-2):45-57. Epub 2005 Jul 11.

PMID:
16009381

Supplemental Content

Support Center